--- title: Simsen Diagnostics to exhibit at ESMO Congress 2026 in Madrid description: Diagnostics exhibits at ESMO Congress 2026, 23 to 27 October, IFEMA Madrid, Hall 8, booth 8043. Book a meeting about tumour-informed ctDNA monitoring. image: https://simsendiagnostics.com/hubfs/GoingToESMO2026_BlogPost-3.png --- [Skip to the main content.](https://simsendiagnostics.com/news/simsen-diagnostics-esmo-congress-2026-madrid#main-content) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) Search [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLJcvC0FL6HWpzbhVicE9CUJ1FdN1tmdunxelYN%2FlSysw9rlvFVf%2BX0TpDx9XsDVaZ1NEWK1NCQ86sVDoaP875%2F%2Bu0wqIyYnEMHxavpuFXlrjd%2FF2%2FcbZXu81Z0Y%2Bkt0NfxfusgmIgciNuW1WiQwCVJcbK63o6vUiTcyR6PycA6erQW1WguU4uJ89yD96jwY%2FgVanMlV&webInteractiveContentId=412216133822&portalId=25734893) Toggle Menu Search Toggle Menu [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLJcvC0FL6HWpzbhVicE9CUJ1FdN1tmdunxelYN%2FlSysw9rlvFVf%2BX0TpDx9XsDVaZ1NEWK1NCQ86sVDoaP875%2F%2Bu0wqIyYnEMHxavpuFXlrjd%2FF2%2FcbZXu81Z0Y%2Bkt0NfxfusgmIgciNuW1WiQwCVJcbK63o6vUiTcyR6PycA6erQW1WguU4uJ89yD96jwY%2FgVanMlV&webInteractiveContentId=412216133822&portalId=25734893) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) [For clinical trials Pharma and CROs Validate MRD endpoints, cut trial-arm cost, build EU regulatory readiness. Design a trial assay →](https://simsendiagnostics.com/solutions-trials) [For research and labs Translational oncology See signal in paediatric and early-stage samples your current platform misses. Send samples or run SiMSen-Seq in-house. See the signal →](https://simsendiagnostics.com/solutions-research) [For clinics Premium oncology monitoring Detect minimal residual disease ahead of imaging. Logistics across the EU, UK and EEA. Detect relapse earlier →](https://simsendiagnostics.com/solutions-clinic) [Home](https://simsendiagnostics.com/) / [Company](https://simsendiagnostics.com/company-about) / [News](https://simsendiagnostics.com/news) / Simsen Diagnostics to exhibit at ESMO Congress 2026 in Madrid [← Back to all news](https://simsendiagnostics.com/news) Corporate # Simsen Diagnostics to exhibit at ESMO Congress 2026 in Madrid By **Simsen** September 16, 2026, 9:52:55 AM GMT+02:00 1 min read ![](https://simsendiagnostics.com/hubfs/GoingToESMO2026_BlogPost-3.png) Simsen Diagnostics will exhibit at the ESMO Congress 2026 in Madrid, 23 to 27 October, at IFEMA, Hall 8, booth 8043. If your work touches ctDNA monitoring, in clinical trials, in the laboratory or in the clinic, this is the easiest week of the year to sit down with our team in person. The ESMO Congress is Europe's largest oncology meeting, gathering clinicians, researchers and industry from across the world. For five days, the conversations that usually take weeks of emails and video calls can happen across a table. ### What a conversation at booth 8043 gives you Whether tumour-informed ctDNA monitoring fits your samples is a question best answered in person, with your tumour types, your sample logistics and your timelines on the table. At the booth you can work through: **Method fit for your question.** ctDNA monitoring approaches are not interchangeable: SNV-based, SV-based and tumour-naive methods each suit different tumour types and study designs. We will tell you honestly which fits your case, including when it is not us. **Where the test runs, and who holds the data.** Run monitoring as a full service from our EU laboratory, or bring the method into your own laboratory with LabSuite on the Illumina sequencers you already own. Either way, samples and data stay in the EU and the raw sequencing data is yours. **A monitoring panel from the material you actually have.** Tumour tissue, or existing sequencing data where no fresh biopsy is available: bring your starting point and we will map the route to a personalised panel. ### Book a meeting Meeting slots during the congress fill quickly. To reserve a time with the team at booth 8043, [contact us here](https://simsendiagnostics.com/contact) and mention ESMO. Drop-by visitors are always welcome too: Hall 8, booth 8043, on the corner by the catering area. ### About Simsen Diagnostics Simsen Diagnostics provides tumour-informed ctDNA analysis for European oncology, built on the peer-reviewed SiMSen-Seq method. Each patient's own tumour mutations are tracked in plasma or cerebrospinal fluid over time, delivered as a full service from our laboratory in Mölndal, Sweden, or in-house in your own laboratory. All analysis is performed within the EU. #### Share [mailto:?subject=Simsen+Diagnostics+to+exhibit+at+ESMO+Congress+2026+in+Madrid&body=https%3A%2F%2Fsimsendiagnostics.com%2Fnews%2Fsimsen-diagnostics-esmo-congress-2026-madrid](mailto:?subject=Simsen+Diagnostics+to+exhibit+at+ESMO+Congress+2026+in+Madrid&body=https%3A%2F%2Fsimsendiagnostics.com%2Fnews%2Fsimsen-diagnostics-esmo-congress-2026-madrid) #### On this page ## More from Simsen ### [June 16, 2026, 3:23:28 PM GMT+02:00 · Corporate Closing the gap between cancer research and patients is partly a question of where the test runs](https://simsendiagnostics.com/news/momentum2026-pre-event) ### [December 17, 2025, 11:57:23 AM GMT+01:00 · Corporate From more treatment to smarter treatment: how tumour‑informed ctDNA monitoring can reduce harm and free capacity in cancer care](https://simsendiagnostics.com/news/from-more-treatment-to-smarter-treatment-how-tumour-informed-ctdna-monitoring-can-reduce-harm-and-free-capacity-in-nordic-cancer-care) ### [November 17, 2025, 3:30:46 PM GMT+01:00 · Corporate Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial](https://simsendiagnostics.com/news/simsen-diagnostics-partners-with-one-carbon-pharmaceuticals-for-groundbreaking-odin-cancer-trial) Talk to us ## Running a trial or service that needs this kind of signal? Tell us about your study and your endpoints. A real scientist in CET/CEST will reply. [Request a conversation](https://simsendiagnostics.com/start-a-conversation) [Back to all news](https://simsendiagnostics.com/news) ![full_lockup_white_CMYK kopia](https://simsendiagnostics.com/hs-fs/hubfs/full_lockup_white_CMYK%20kopia.png?width=166&height=45&name=full_lockup_white_CMYK%20kopia.png) **Visiting and postal address:** Pepparedsleden 1 431 53 Mölndal, Sweden **Shipping address:** c/o AstraZeneca R&D Mölndal Pepparedsleden 3 431 53 Mölndal, Sweden PLATFORM PLATFORM - [Platform overview](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) SOLUTIONS SOLUTIONS - [For clinical trials](https://simsendiagnostics.com/solutions-trials) - [For research and labs](https://simsendiagnostics.com/solutions-research) - [For clinics](https://simsendiagnostics.com/solutions-clinic) - [Solutions overview](https://simsendiagnostics.com/solutions-overview) COMPANY COMPANY - [About](https://simsendiagnostics.com/company-about) - [News](https://simsendiagnostics.com/news) - [Team](https://simsendiagnostics.com/company-team) - [Contact](https://simsendiagnostics.com/company-contact) - [Privacy policy](https://simsendiagnostics.com/legal-privacy-policy) - [Cookie Policy](https://simsendiagnostics.com/legal-cookie-policy) - [Terms of use](https://simsendiagnostics.com/legal-terms-of-use) © 2026 Simsen Diagnostics AB, All rights reserved. [Linkedin](https://www.linkedin.com/company/simsendiagnostics) Return to top ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Simsen", "url" : "https://simsendiagnostics.com/news/author/simsen" }, "dateModified" : "2026-09-16T07:52:55.311Z", "datePublished" : "2026-09-16T07:52:55.000Z", "headline" : "Simsen Diagnostics to exhibit at ESMO Congress 2026 in Madrid", "image" : [ "https://simsendiagnostics.com/hubfs/GoingToESMO2026_BlogPost-3.png" ], "mainEntityOfPage" : { "@id" : "https://simsendiagnostics.com/news/simsen-diagnostics-esmo-congress-2026-madrid", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://simsendiagnostics.com/hubfs/SD_logo%20medium-2.png" }, "name" : "Simsen Diagnostics AB" } } ```